Biblio Discovery — Demo Discovery Service

6 results for "Nicolas Faller"

Showing 1–6 · 1.73 seconds · RSS

  1. Journal Article Full text

    Functional analysis of a missense mutation in the serine protease inhibitor SPINT2 associated with congenital sodium diarrhea.

    Nicolas Faller; Ivan Gautschi; Laurent Schild

    PLoS ONE, Vol. 9 No. 4 · 2014 · English · DOAJ Scopus

    Membrane-bound serine proteases play important roles in different biological processes. Their regulation by endogenous inhibitors is poorly understood. A Y163C mutation in the SPINT2 gene encoding the serine protease inhibitor Hepatocyte Growth Factor Inhibitor HAI-2 is associated with a congenital…

    Also available at: PLOS

  2. Journal Article Full text

    Educational Level, Anticoagulation Quality, and Clinical Outcomes in Elderly Patients with Acute Venous Thromboembolism: A Prospective Cohort Study.

    Eveline Hofmann; Nicolas Faller; Andreas Limacher et al.

    PLoS ONE, Vol. 11 No. 9 · 2016 · English · DOAJ Scopus

    Whether the level of education is associated with anticoagulation quality and clinical outcomes in patients with acute venous thromboembolism (VTE) is uncertain. We thus aimed to investigate the association between educational level and anticoagulation quality and clinical outcomes in elderly…

    Also available at: PLOS

  3. Journal Article

    Impact of the SGLT2 inhibitor empagliflozin on urinary supersaturations in kidney stone formers (SWEETSTONE trial): protocol for a randomised, double-blind, placebo-controlled cross-over trial

    Simeon Schietzel; Felix Rintelen; S Trelle et al.

    BMJ Open, Vol. 12 No. 3 · 2022 · English · DOAJ Scopus

    Introduction Kidney stones are a global healthcare problem. Given high recurrence rates and the morbidity associated with symptomatic stone disease, effective medical prophylaxis is clearly an unmet need. Explanatory analyses of randomised controlled trials with sodium/glucose cotransporter isoform…

  4. Journal Article

    Efficacy of standard and low dose hydrochlorothiazide in the recurrence prevention of calcium nephrolithiasis (NOSTONE trial): protocol for a randomized double-blind placebo-controlled trial

    Nasser A. Dhayat; Nicolas Faller; Olivier Bonny et al.

    BMC Nephrology, Vol. 19 No. 1 · 2018 · English · DOAJ Scopus

    Abstract Background Nephrolithiasis is a global healthcare problem with a current lifetime risk of 18.8% in men and 9.4% in women. Given the high cost of medical treatments and surgical interventions as well as the morbidity related to symptomatic stone disease, medical prophylaxis for stone…